# Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

> **NCT04846439** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 20 (estimated)

## Conditions studied

- Platelet Transfusion Refractoriness
- Acute Leukemia in Remission

## Interventions

- **BIOLOGICAL:** CAR-T infusion

## Key facts

- **NCT ID:** NCT04846439
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-29
- **Primary completion:** 2023-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04846439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04846439, "Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04846439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*